Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 01-2025 | 10-2024 | 07-2024 | 04-2024 | 01-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 277 | 421 | 424 | 517 | 632 |
| Receivables | 180 | 371 | 298 | 234 | 171 |
| Inventories | 75 | 72 | 56 | 74 | 74 |
| TOTAL | $562 | $911 | $805 | $869 | $939 |
| Non-Current Assets | |||||
| PPE Net | 12 | 13 | 13 | 51 | 147 |
| TOTAL | $12 | $13 | $13 | $51 | $147 |
| Total Assets | $574 | $924 | $818 | $920 | $1,086 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 700 | 718 | 601 | 506 | 409 |
| Accrued Expenses | 166 | 193 | 132 | 160 | 136 |
| TOTAL | $866 | $911 | $733 | $666 | $545 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,975 | 3,509 | 2,949 | 2,400 | 1,862 |
| TOTAL | $3,975 | $3,509 | $2,949 | $2,400 | $1,862 |
| Total Liabilities | $4,841 | $4,420 | $3,682 | $3,066 | $2,407 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 111,857 | 111,857 | 111,857 | 111,857 | 111,857 |
| Common Shares | 1,119 | 1,119 | 1,119 | 1,119 | 1,119 |
| Retained earnings | -138,082 | -137,284 | -136,595 | -135,839 | -134,982 |
| TOTAL | $-4,267 | $-3,496 | $-2,864 | $-2,146 | $-1,321 |
| Total Liabilities And Equity | $574 | $924 | $818 | $920 | $1,086 |